HanchorBio FDA Orphan Drug Designation Boosts HCB101 for Gastric Cancer
HanchorBio has achieved a major regulatory milestone with the HanchorBio FDA orphan drug designation for HCB101. The designation supports the development of the company’s next-generation immunotherapy for gastric cancer,...
